NCT06033768

Brief Summary

Evaluation of neurological and psychological complications in children diagnosed as neurocutaneous syndromes in upper Egypt

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2023

Typical duration for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 3, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 13, 2023

Completed
18 days until next milestone

Study Start

First participant enrolled

October 1, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

September 13, 2023

Status Verified

September 1, 2023

Enrollment Period

2 years

First QC Date

September 3, 2023

Last Update Submit

September 10, 2023

Conditions

Neurocutaneous Syndromes

Outcome Measures

Primary Outcomes (4)

  • epilepsy

    prevalence of epilepsy in children with neurocutaneous syndromes

    baseline

  • autism spectrum

    prevalence of autism spectrum in children with neurocutaneous syndromes

    baseline

  • attention deficit hyperactivity syndrome

    prevalence of attention deficit hyperactivity syndrome in children with neurocutaneous syndromes

    baseline

  • depression

    prevalence of depression in children with neurocutaneous syndromes

    bsaeline

Eligibility Criteria

Age1 Month - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

his study will be carried out in outpatient clinic and inpatient department in Assiut University Children's Hospital .

You may qualify if:

  • \- All children with sign and symptoms of neurocutneous syndromes.

You may not qualify if:

  • Children with pigmentary and neurological disorders other than neurocutneous syndromes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Neurocutaneous Syndromes

Condition Hierarchy (Ancestors)

Nervous System DiseasesEctodermal DysplasiaAbnormalities, MultipleCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesSkin AbnormalitiesSkin Diseases, GeneticGenetic Diseases, InbornSkin DiseasesSkin and Connective Tissue Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
doctor

Study Record Dates

First Submitted

September 3, 2023

First Posted

September 13, 2023

Study Start

October 1, 2023

Primary Completion

October 1, 2025

Study Completion

December 1, 2025

Last Updated

September 13, 2023

Record last verified: 2023-09